# 11.2 Capital

> 11.2 Capital is a VC fund backing Software and Information Technology. See 58 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: San Francisco, United States
- Total investments: 58
- Last investment: Aug 2024
- Lead investor: 12%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/10485200?trk=prof-exp-company-name
- Website: http://www.112capital.com

11.2 Capital is a VC fund in San Francisco focused on Software and Information Technology. In physics, 11.2 km/s is the escape velocity from Earth's gravity. They focus on emerging technologies such as AI, cybersecurity, robotics, quantum, new space, computational therapeutics, synthetic biology. ​They believe great people are leading indicators of a company's success. 11.2 Capital’s technical background, operationalexperience, and a strong network of amazing advisors and international partners particularly in Asia deliver a unique set of resources to entrepreneurs. While they are happy to help companies across the full range of early-stage company questions, areas where they concentrate include technical recruiting, partnerships (OEM and distribution partnerships for smart hardware companies, data partnerships for data-driven healthcare companies), customer introductions (CISO introductions for security companies, provider introductions for healthcare companies), and follow-on financings.

## Contacts

5 contacts available for 11.2 Capital. Shizune tracks 4 team members at 11.2 Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/112capital?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $1M–$12M |
| Series A | $7.3M–$26M |
| Series B | $15M–$53M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 15 | 26% |
| Information Technology | 11 | 19% |
| Biotechnology | 9 | 16% |
| Artificial Intelligence | 9 | 16% |
| Health Care | 8 | 14% |

80 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 22 | 38% |
| Series A | 16 | 28% |
| Series B | 6 | 10% |
| Convertible Note | 3 | 5% |
| Venture - Series Unknown | 3 | 5% |

9 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 34 | 59% |
| Canada | 3 | 5% |
| United Kingdom | 2 | 3% |
| Germany | 1 | 2% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| David Dorsey | Partner | 0 | https://shizune.co/investors/profile/david-dorsey |
| Jacob Smith | Principal | 4 | https://shizune.co/investors/profile/jacob-smith-02b4 |
| Pramod Gosavi | Principal, Investor | 3 | https://shizune.co/investors/profile/pramod-gosavi |
| Shelley Zhuang | Founder & Managing Partner | 7 | https://shizune.co/investors/profile/shelley-zhuang |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Noetik | Noetik is an AI-native biotechnology company. Noetik leverages in advanced machine learning methods to discover and develop cancer immunotherapies. | $40M | Series A | Aug 28, 2024 |  |
| Mantle | Mantle is an engineering and manufacturing company that has developed metal 3D printing technology to produce high-resolution parts that meet the critical needs of applications from automotive and aerospace to consumer product design and prototyping. | $20M | Series C | Jul 10, 2024 |  |
| Coalesce Automation | Coalesce Automation develops data management platforms that automate data activities. The company's platform combines the speed of an intuitive graphical user interface (GUI), the flexibility of code, and the effectiveness of data transformation automation, allowing businesses to obtain effective data management and analytics capabilities. | $50M | Series B | Apr 04, 2024 |  |
| Leen | Leen is a unified API for security tools and data. | $2.8M | Pre-Seed | Mar 25, 2024 |  |
| Thea Energy | Thea Energy is taking a faster approach to commercialize fusion energy. The company’s fusion systems will create a limitless source of zero emission energy for a sustainable future.Thea Energy is leveraging recent breakthroughs in stellarator physics and engineering developed at Princeton University and elsewhere. The company was founded in 2022with the objective of building modular, utility-scale fusion power. | $20M | Series A | Feb 08, 2024 |  |
| Quintessent | Quintessent is a Santa Barbara start-up that commercializes quantum dot-based lasers and photonic integrated circuits. Its solutions leverage the unique properties of quantum dot gain media with co-designed architectures to enable future applications in optical networking, deep learning systems, and sensing.It is based in Santa Barbara,California. | $11.6M | Seed | Oct 26, 2023 |  |
| Kolena | Kolena is an ML testing platform that allows ML teams to rigorously test their model behavior. With Kolena, ML teams can identify and track failure modes to help engineering, sales, and customers better understand model performance and identify gaps. Kolena is the creator of a machine learning testing and analytics platform used to ensure thequality of machine learning and related technologies. Clients can use the company's platform to streamline and rectify machine learning and analytics projects by providing a testing infrastructure for machine learning software models and updates. | $15M | Series A | Sep 26, 2023 |  |
| Noetik | Noetik is an AI-native biotechnology company. Noetik leverages in advanced machine learning methods to discover and develop cancer immunotherapies. | $14M | Seed | Sep 07, 2023 |  |
| Umedeor | uMed is a technology platform embedded across a global network of healthcare providers that automates the process of building prospective, protocolized patient registries. This enables sites to participate in dozens of programmes simultaneously without increasing overhead or burden on staff. For life science companies, uMed provides access toregulator quality data, where patients within those datasets can be compliantly re-engaged to support the aims of R&D and post-market teams | $12.8M | Series A | Jul 05, 2023 |  |
| Hubble Network | a Satellite network connecting billions of bluetooth devices. GLOBALLY. | $20M | Series A | May 29, 2023 |  |

10 of 58 investments shown.

## Co-investors
- [DCVC](https://shizune.co/investors/profile/data-collective) — VC Fund, 5 deals together
- [Atomico](https://shizune.co/investors/profile/atomico) — VC Fund, 4 deals together
- [Foundation Capital](https://shizune.co/investors/profile/foundation-capital) — VC Fund, 4 deals together
- [AlbionVC](https://shizune.co/investors/profile/albion-vc) — VC Fund, 3 deals together
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund, 3 deals together
- [Corazon Capital](https://shizune.co/investors/profile/corazon-capital) — VC Fund, 3 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [Alexandria Venture Investments](https://shizune.co/investors/profile/alexandria-venture-investments) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## Featured in investor lists
- [Life Science Investors in United Kingdom](https://shizune.co/investors/life-science-investors-united-kingdom)
- [Life Science VC Funds in United Kingdom](https://shizune.co/investors/life-science-vc-funds-united-kingdom)
- [Life Science VC Funds in Europe](https://shizune.co/investors/life-science-vc-funds-europe)
- [Life Science Investors in Europe](https://shizune.co/investors/life-science-investors-europe)
- [Clean Energy VC Funds in United States](https://shizune.co/investors/clean-energy-vc-funds-united-states)
- [Clean Energy Investors in United States](https://shizune.co/investors/clean-energy-investors-united-states)

## FAQ

### What does 11.2 Capital invest in?

11.2 Capital invests primarily in Software, Information Technology and Biotechnology startups, most often at Seed and Series A stage. Most of the 58 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is 11.2 Capital's check size?

11.2 Capital typically joins rounds of $1M–$12M at Seed, $7.3M–$26M at Series A and $15M–$53M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds 11.2 Capital participates in.

### How do I contact 11.2 Capital?

Public channels for 11.2 Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at 11.2 Capital?

The team at 11.2 Capital includes David Dorsey (Partner), Jacob Smith (Principal) and Pramod Gosavi (Principal, Investor). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co
